| Aktie | Ticker | Breite | GCS | 2026/Q1 | 2025/Q4 | 2025/Q3 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| 11.758.270 $ | -11.430.294 $ | -28,6 % | 7 | 24.632.218 $ | +9.219.282 $ | +33,0 % | 10 | 16.413.103 $ | -217.407 $ | +5,5 % | 8 | ||||
| Beta Bionics, Inc. | BBNX | → 0 | Schwach | 2.818.125 $ | -5.751.563 $ | -67,1 % | 1 | 8.569.688 $ | +2.981.250 $ | +53,3 % | 1 | 5.588.438 $ | -659.549 $ | -10,6 % | 1 |
| Insight Molecular Diagnostics Inc. | IMDX | → 0 | Neutral | 3.106.600 $ | -3.996.905 $ | -56,3 % | 1 | 7.103.505 $ | +3.959.020 $ | +125,9 % | 1 | 3.144.485 $ | +284.140 $ | +9,9 % | 1 |
| ESTABLISHMENT LABS HOLDINGS INC. | ESTA | → 0 | Neutral | 2.555.100 $ | -724.500 $ | -22,1 % | 1 | 3.279.600 $ | +1.435.050 $ | +77,8 % | 1 | 1.844.550 $ | -77.400 $ | -4,0 % | 1 |
| Caris Life Sciences, Inc. | CAI | → 0 | Neutral | 1.608.127 $ | -818.454 $ | -33,7 % | 1 | 2.426.581 $ | -294.104 $ | -10,8 % | 1 | 2.720.685 $ | +317.488 $ | +13,2 % | 1 |
| InspireMD, Inc. | NSPR | → 0 | 734.343 $ | -67.577 $ | -8,4 % | 1 | 801.920 $ | -283.826 $ | -26,1 % | 1 | 1.085.746 $ | +63.072 $ | +6,2 % | 1 | |
| Outset Medical, Inc. | OM | → 0 | Neutral | 1.000.167 $ | -360.541 $ | -26,5 % | 1 | ||||||||
| Metagenomi Therapeutics, Inc. | MGX | → 0 | Neutral | 428.313 $ | -198.294 $ | -31,6 % | 1 | 626.607 $ | +235.308 $ | +60,1 % | 1 | ||||
| MICROSOFT CORP | MSFT | → 0 | Neutral | 580.344 $ | +580.344 $ | 1 | |||||||||
| Natera, Inc. | NTRA | → 0 | Neutral | 499.975 $ | -72.750 $ | -12,7 % | 1 | 572.725 $ | +170.300 $ | +42,3 % | 1 | 402.425 $ | -19.925 $ | -4,7 % | 1 |
| NVIDIA CORP | NVDA | → 0 | Neutral | 436.000 $ | +1.455 $ | +0,3 % | 1 | 434.545 $ | +434.545 $ | 1 | |||||
| JPMORGAN CHASE & CO | JPM | → 0 | Neutral | 434.997 $ | +434.997 $ | 1 | |||||||||
| 11.758.270 $ | -11.430.294 $ | -28,6 % | 7 | 24.632.218 $ | +9.219.282 $ | +33,0 % | 10 | 16.413.103 $ | -217.407 $ | +5,5 % | 8 | ||||